PCN137 COST COMPARISON OF ADVERSE EVENTS AND TREATMENT ADMINISTRATION OF LURBINECTEDIN VERSUS INTRAVENOUS TOPOTECAN FOR RELAPSED SMALL CELL LUNG CANCER IN SPAIN AND THE UNITED KINGDOM
García San Andrés, B., Ubi, S., Alvarez-Alvarez, R., Barwood, C., Olmedo-García, M.E., Foster, M.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.333
Date:
November, 2019
File:
PDF, 381 KB
english, 2019